Top Story

PUBLICATION EXCLUSIVE: Young woman who went blind in one eye presents years later with symptoms in fellow eye

June 22, 2017

A 21-year-old Hispanic woman presented to the University of New Mexico with a 1-month history of worsening flashes of light and scotomas in her left superior field of vision.

Regarding her medical and ocular history, the patient had previously been diagnosed with a “generalized vasculitis.” When she was 14 years old, she developed joint pain in her wrists, ankles and knees. Within a week of the onset of the arthralgias, she also lost vision in the right eye and has since only seen bare light perception in that eye. She was followed by an outside ophthalmologist who told her he had seen “inflammation and a vitreous hemorrhage” in her right eye. She subsequently had a vitrectomy with no improvement in her vision. According to the patient, she had a complete systemic workup at that time that was unremarkable. Medical records provided by the patient indicated that her working diagnosis was “lupus retinal vasculitis.” However, the patient refuted this diagnosis, reporting that she had tested negative. She was followed closely by a rheumatologist who had prescribed her a high dose of methotrexate, which she was able to be weaned off within 2 years at age 16 given that she had not experienced any subsequent flares. Since that time, she had moved to Albuquerque, New Mexico, but had not re-established immediate care with a new rheumatologist.

Senate health care bill takes slower approach to House bill, expert concerns persist

June 22, 2017
The Senate health care bill, released to the public today, maintains much from the version the House passed May 4, 2017, but presents some key changes such as a slower…
In the Journals

Two iStent injects and topical travoprost reduce IOP, medication use through 18 months

June 22, 2017
The implantation of two second-generation iStent inject devices and postoperative topical prostaglandin in eyes with open-angle glaucoma reduced mean IOP and medication…

Marketing authorization application filed in Europe for Durasert 3-year uveitis treatment

June 22, 2017
A marketing authorization application has been filed to the European Medicines Agency for the approval to market Durasert 3-year treatment for posterior segment uveitis…

NovaBay reports $4 million quarterly loss

June 22, 2017
NovaBay Pharmaceuticals announced a $4 million net loss in the first quarter of 2017 compared with a net loss of $5.1 million in the same quarter of last year. Research…
More News Headlines »
Original Article

Meta-analysis of the FDA Reports on Patient-Reported Outcomes Using the Three Latest Platforms for LASIK

Journal of Refractive Surgery, June 2017, Volume 33 Issue 6
To analyze the impact of the three latest U.S. Food and Drug Administration (FDA)–approved lasers on patient-reported…
More »

Scratching Beneath the Surface to Manage Ocular Surface Disease

This activity is supported by an educational grant from Shire.

Dry eye disease (DED) is a condition of the ocular surface in which multiple factors are responsible for the…
More »
Meeting News

VIDEO: Brimonidine investigated for preserving vision in glaucoma and retina disease

June 21, 2017
More »